Skip to main content

Smart Insulin Pens Market Technology Advancements | Analysis by Manufacturers to Study New Developments

Smart insulin pens are devices used to deliver the accurate dose of insulin to diabetics at the appropriate time. They have gained traction among diabetics due to its simplistic nature and easy to handle mechanism compared to traditional syringes. The global smart insulin pens market report by Market Research Future (MRFR) contains the pertinent drivers and challenges faced by manufacturers during the period of 2018 to 2023.
Market Overview
The global smart insulin pens market is expected to exhibit 10.4% CAGR during the forecast period (2018-2023) due to high prevalence of diabetes. Furthermore, the use of these devices for the management of diabetes by the general populace in developing countries can bode well for the market during the forecast period. Awareness of advanced drug delivery methods, need for modern treatments, and the alarming cases of diabetes can bolster the global market demand till 2023.
The surge in the adoption rate of glucose monitoring devices, awareness of these devices, and integration of glucose measurement devices are other drivers of the market. According to the World Health Organization (WHO), diabetes was accountable for 1.2 million deaths in 2012. This can spark the demand for smart insulin pens for proper management of diabetes. Co-pay assistance and medical reimbursement policies covering the purveying of these devices can ensure the continuous sales.
Unfavorable reimbursement policies, risks associated with insulin pens, and increasing costs of insulin pens are challenges faced by the market.
Major Market Competitive Outlook
These are the notable players of the global smart insulin pens market. Manufacturers are launching new iterations of smart insulin pens for recording the proper dosage amounts and reminders of taking insulin shots at the appropriate time.
InjexUK
Lilly USA
LLC
Digital Medics Pvt Ltd.
Companion Medical
Sanofi-Aventis US LLC
Diamesco Co. Ltd.
Smith’s Medical
NIPRO Medical Corporation
Novo Nordisk A/S
Biocorp
Emperra GmbH E-Health Technologies
and others. For instance, the InPen by Companion Medical can capture mealtime data and shares it on the respective medical mobile application.
Industry News
Recently, Medtronic and Novo Nordisk have decided to pool in their offerings for sharing the data acquired by their smart insulin pens on a common diabetes management platform.
Market Segmentation
The global smart insulin pens market has been segmented on the basis of product type, usability, and distribution channel.
On the basis of product type, the market has been segmented into first-generation pens and second-generation pens. The second-generation pens segment has been further divided into Bluetooth-enabled and USB connected.
By usability, the segment has been divided into disposable pens and reusable pens. Reusable insulin pens segment is likely to be the fastest growing segment during the forecast period.
by distribution channel, has been segmented into retail pharmacies, diabetes clinics, online medical stores, and hospital pharmacies.
Browse Complete Details of “Smart Insulin Pens Market” Here: https://www.marketresearchfuture.com/reports/smart-insulin-pens-market-6789
Regional Analysis
The Middle East & Africa (MEA), Americas, Asia Pacific (APAC), and Europe are regions discussed in the global smart insulin pens market report.
The Americas can be the leading region of the global market till 2023 due to favorable policies by regulatory authorities, adoption of advanced technology, and rising prevalence of diabetes among the general populace. The approval of novel injectable devices by regulatory agencies can drive the global smart insulin pens market growth.
The Europe smart insulin pens market is driven by adoption of advanced drug delivery devices, rising cases of diabetics, and presence of major players. According to the World Diabetes Foundation, more than 59 million have been diagnosed with diabetes, with the number purported to touch 71.1 million by 2040.
Government policies for assisting diabetics and rise in disposable income levels of patients are main drivers of the smart insulin pens market in APAC. Large cases of diabetes recorded in Southeast Asia can drive the regional market growth. As per the International Diabetes Federation, the number of diabetics in the region can touch 156 million by 2045.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more